Canlyniadau Chwilio - Jane Meisel

  • Dangos 1 - 13 canlyniadau o 13
Mireinio'r Canlyniadau
  1. 1
    Overwhelming Watery Diarrhea Associated with a Cryptosporidium in an Immunosuppressed Patient

    Overwhelming Watery Diarrhea Associated with a Cryptosporidium in an Immunosuppressed Patient gan Jane Meisel, David Perera, C. Meligro, C.E. Rubin

    Cyhoeddwyd 1976
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Rectal biopsy in the diagnosis of Crohn's disease: Value of multiple biopsies and serial sectioning

    Rectal biopsy in the diagnosis of Crohn's disease: Value of multiple biopsies and serial sectioning gan Christina M. Surawicz, Jane Meisel, Thomas J. Ylvisaker, David Saunders, C.E. Rubin

    Cyhoeddwyd 1981
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    The role of systemic chemotherapy in the management of granulosa cell tumors

    The role of systemic chemotherapy in the management of granulosa cell tumors gan Jane Meisel, David M. Hyman, Anjali R. Jotwani, Qin Zhou, Nadeem R. Abu‐Rustum, Alexia Iasonos, Malcolm C. Pike, Carol Aghajanian

    Cyhoeddwyd 2014
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Stromal PD-L1 Expression Is Associated With Better Disease-Free Survival in Triple-Negative Breast Cancer

    Stromal PD-L1 Expression Is Associated With Better Disease-Free Survival in Triple-Negative Breast Cancer gan Xiaoxian Li, Ceyda Sönmez Wetherilt, Uma Krishnamurti, Jing Yang, Yamin Ma, Toncred M. Styblo, Jane Meisel, Limin Peng, Momin T. Siddiqui, Cynthia Cohen, Ritu Aneja

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Development of a risk stratification system to guide treatment for female germ cell tumors

    Development of a risk stratification system to guide treatment for female germ cell tumors gan Jane Meisel, Kaitlin M. Woo, Nora Sudarsan, Jana Eng, Sujata Patil, Erin Jacobsen, Rajmohan Murali, Ginger J. Gardner, George J. Bosl, Carol Aghajanian, Darren R. Feldman

    Cyhoeddwyd 2015
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    TROPION-Breast04: a randomized phase III study of neoadjuvant datopotamab deruxtecan (Dato-DXd) plus durvalumab followed by adjuvant durvalumab versus standard of care in patients with treatment-naïve early-stage triple negative or HR-low/HER2− breast cancer

    TROPION-Breast04: a randomized phase III study of neoadjuvant datopotamab deruxtecan (Dato-DXd) plus durvalumab followed by adjuvant durvalumab versus standard of care in patients... gan Heather L. McArthur, Sara M. Tolaney, Rebecca Dent, Peter Schmid, Jamil Asselah, Qiang Liu, Jane Meisel, Naoki Niikura, Winnie Yeo, Gustavo Werutsky, Giampaolo Bianchini, Jay C. Andersen, Robert Kozarski, Nana Rokutanda, Barbara Pistilli, Sibylle Loibl

    Cyhoeddwyd 2025
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    159TiP TROPION-Breast04: Phase (ph) III study of neoadjuvant (neoadj) datopotamab deruxtecan (Dato-DXd) + durvalumab (D) followed by adjuvant (adj) D vs standard of care (SoC) in treatment-naïve, triple-negative (TN) and HR-low/HER2- breast cancer (BC)

    159TiP TROPION-Breast04: Phase (ph) III study of neoadjuvant (neoadj) datopotamab deruxtecan (Dato-DXd) + durvalumab (D) followed by adjuvant (adj) D vs standard of care (SoC) in t... gan Sibylle Loibl, S.M. Tolaney, P. Schmid, Barbara Pistilli, Rebecca Dent, Jamil Asselah, Q. Liu, Jane Meisel, Naoki Niikura, Y.H. Park, G. Werutsky, Giampaolo Bianchini, J.C. Andersen, R. Kozarski, N. Rokutanda, Heather L. McArthur

    Cyhoeddwyd 2024
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    A randomized, controlled phase II trial of neoadjuvant ado-trastuzumab emtansine, lapatinib, and nab-paclitaxel versus trastuzumab, pertuzumab, and paclitaxel in HER2-positive breast cancer (TEAL study)

    A randomized, controlled phase II trial of neoadjuvant ado-trastuzumab emtansine, lapatinib, and nab-paclitaxel versus trastuzumab, pertuzumab, and paclitaxel in HER2-positive brea... gan Tejal Patel, Joe Ensor, Sarah L. Creamer, Toniva Boone, Angel Rodriguez, Poly A. Niravath, Jorge Darcourt, Jane Meisel, Xiaoxian Li, Jing Zhao, John G. Kuhn, Roberto R. Rosato, Wei Qian, Anna Belcheva, Mary R. Schwartz, Virginia Kaklamani, Jenny C. Chang

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Drug-drug interactions between palbociclib and proton pump inhibitors in early breast cancer: an exploratory analysis of PALLAS (ABCSG-42/AFT-05/BIG-14-13/PrE0109)

    Drug-drug interactions between palbociclib and proton pump inhibitors in early breast cancer: an exploratory analysis of PALLAS (ABCSG-42/AFT-05/BIG-14-13/PrE0109) gan Elisa Agostinetto, Georg Pfeiler, Dominik Hlauschek, Erica L. Mayer, Matteo Lambertini, Evandro de Azambuja, M. Bellet-Ezquerra, Jane Meisel, Gábor Rubovszky, Nicholas Zdenkowski, Yelena Novik, Manuel Ruíz‐Borrego, Karen A. Gelmon, Eleftherios P. Mamounas, Hiroji Iwata, Dongrui R. Lu, Lidija Soelkner, Christian Fesl, Michael Gnant, Angela DeMichele

    Cyhoeddwyd 2025
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Gene expression associated with endocrine therapy resistance in estrogen receptor-positive breast cancer

    Gene expression associated with endocrine therapy resistance in estrogen receptor-positive breast cancer gan Veronica Jones, Hongwei Yin, Yuan Yuan, Yongzhe Wang, Sierra Min Li, Dana Aljaber, Angelica Sanchez, Christine Quinones, Daniel Schmolze, Yuan Yuan, Joanne Mortimer, Lisa D. Yee, Laura Kruper, Tijana Jovanović‐Talisman, Jerneja Tomšič, Nancy Sanchez, Tanya Chavez, Ruth O’Regan, Qamar J. Khan, Melissa B. Davis, Kevin Kalinsky, Jane Meisel, Rick A. Kittles, Lorna Rodrı́guez-Rodrı́guez, Victoria L. Seewaldt

    Cyhoeddwyd 2025
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Diverse <i>BRCA1</i> and <i>BRCA2</i> Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer

    Diverse <i>BRCA1</i> and <i>BRCA2</i> Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer gan Britta Weigelt, Iñaki Comino‐Méndez, Ino de Bruijn, Lei Tian, Jane Meisel, Isaac García-Murillas, Charlotte Fribbens, Ros Cutts, Luciano G. Martelotto, Charlotte K.Y. Ng, Raymond S. Lim, Pier Selenica, Salvatore Piscuoglio, Carol Aghajanian, Larry Norton, Rajmohan Murali, David M. Hyman, Laetitia Borsu, Maria E. Arcila, Jason Konner, Jorge S. Reis‐Filho, Roger A. Greenberg, Mark E. Robson, Nicholas C. Turner

    Cyhoeddwyd 2017
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Clinical Cancer Advances 2021: ASCO's Report on Progress Against Cancer

    Clinical Cancer Advances 2021: ASCO's Report on Progress Against Cancer gan Sonali M. Smith, KERRI WACHTER, Howard A. Burris, Richard L. Schilsky, Daniel J. George, Douglas E. Peterson, Melissa L. Johnson, Merry Jennifer Markham, Kathryn F. Mileham, Muhammad Shaalan Beg, Johanna C. Bendell, Robert Dreicer, Vicki L. Keedy, Randall J. Kimple, Miriam A. Knoll, Noelle K. LoConte, Helen Mackay, Jane Meisel, Timothy J. Moynihan, Daniel A. Mulrooney, Therese M. Mulvey, Olatoyosi Odenike, Nathan A. Pennell, Katherine E. Reeder‐Hayes, Cardinale B. Smith, Ryan J. Sullivan, Robert G. Uzzo

    Cyhoeddwyd 2021
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Quality-of-life and symptom severity in the PALLAS randomized trial of palbociclib with adjuvant endocrine therapy in early breast cancer (AFT-05, ABCSG-42, BIG-14-03, PrE0109)

    Quality-of-life and symptom severity in the PALLAS randomized trial of palbociclib with adjuvant endocrine therapy in early breast cancer (AFT-05, ABCSG-42, BIG-14-03, PrE0109) gan Michelle J. Naughton, D M Zahrieh, Michael Gnant, Nicholas Zdenkowski, Julie Lemieux, Jun J. Mao, Vesna Bjelic‐Radisic, Eileen H. Shinn, Marija Balić, C. Thomssen, Jane Meisel, García Erika Ruiz, Sibylle Loibl, Claudine Isaacs, David Cameron, Fernando Henao, Matthew P. Goetz, C.F. Singer, Gustavo Werutsky, H.S. Rugo, Marcus Vetter, Ling‐Ming Tseng, Kathy D. Miller, Florian Fitzal, Miguel Gil‐Gil, H. Park, B. Linderholm, Emilio Bajetta, Zoneddy Dayao, Aleix Prat, Karl Ehrhardt, Otto Metzger, Amal Arahmani, Ernest H. Law, Ann H. Partridge, Lisa A. Carey, Alex Zoroufy, Amylou C. Dueck, Patrick O’Brien, Dominik Hlauschek, Angela DeMichele, Erica L. Mayer

    Cyhoeddwyd 2025
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: